25 XP   0   0   10

Castle Biosciences Inc
Buy, Hold or Sell?

Let's analyse Castle Biosciences Inc together

PenkeI guess you are interested in Castle Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Castle Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Castle Biosciences Inc

I send you an email if I find something interesting about Castle Biosciences Inc.

Quick analysis of Castle Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Castle Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.04
When do you have the money?
1 year
How often do you get paid?
20.8%

What is your share worth?

Current worth
$14.25
Expected worth in 1 year
$13.97
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-0.25
Return On Investment
-1.3%

For what price can you sell your share?

Current Price per Share
$19.51
Expected price per share
$17.42 - $25.36
How sure are you?
50%

1. Valuation of Castle Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$19.51

Intrinsic Value Per Share

$28.51 - $34.80

Total Value Per Share

$42.77 - $49.06

2. Growth of Castle Biosciences Inc (5 min.)




Is Castle Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$391.2m$407.3m-$22.1m-5.8%

How much money is Castle Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$14.3m-$16.4m$2m14.3%
Net Profit Margin-30.5%-50.3%--

How much money comes from the company's main activities?

3. Financial Health of Castle Biosciences Inc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#48 / 145

Most Revenue
#73 / 145

Most Profit
#117 / 145

What can you expect buying and holding a share of Castle Biosciences Inc? (5 min.)

Welcome investor! Castle Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Castle Biosciences Inc.

What can you expect buying and holding a share of Castle Biosciences Inc?

First you should know what it really means to hold a share of Castle Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Castle Biosciences Inc is $19.51. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Castle Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Castle Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $14.25. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Castle Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-0.5%-0.52-2.7%-0.61-3.1%-0.30-1.5%-0.26-1.3%
Usd Book Value Change Per Share0.201.0%-0.07-0.4%-0.11-0.6%0.733.7%0.593.0%
Usd Dividend Per Share0.000.0%0.010.0%0.020.1%0.000.0%0.000.0%
Usd Total Gains Per Share0.201.0%-0.06-0.3%-0.10-0.5%0.743.8%0.603.1%
Usd Price Per Share21.58-18.73-29.11-34.05-28.38-
Price to Earnings Ratio-57.40--21.13--30.14--15.98--13.32-
Price-to-Total Gains Ratio107.98-15.68--47.94-2,429.57-2,429.57-
Price to Book Ratio1.51-1.33-1.97-3.79-3.16-
Price-to-Total Gains Ratio107.98-15.68--47.94-2,429.57-2,429.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share19.51
Number of shares51
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share-0.070.73
Usd Total Gains Per Share-0.060.74
Gains per Quarter (51 shares)-3.1937.53
Gains per Year (51 shares)-12.75150.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12-15-231149140
24-29-362298290
36-44-493447440
48-59-624597590
59-73-755746740
611-88-886895890
713-102-101710441040
815-117-114811931190
917-132-127913421340
1019-146-1401014911490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%3.017.00.015.0%4.020.00.016.7%4.020.00.016.7%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%12.08.00.060.0%12.09.03.050.0%12.09.03.050.0%
Dividend per Share3.00.01.075.0%5.00.07.041.7%5.00.015.025.0%5.00.019.020.8%5.00.019.020.8%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%12.08.00.060.0%12.09.03.050.0%12.09.03.050.0%

Fundamentals of Castle Biosciences Inc

About Castle Biosciences Inc

Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett's esophagus. In addition, the company provides DecisionDx-UM test, a proprietary risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide drug treatment for major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. It offers its products to skin cancer, gastroenterology, and mental health markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

Fundamental data was last updated by Penke on 2024-04-11 05:16:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Castle Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Castle Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Castle Biosciences Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -3.9% means that $-0.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Castle Biosciences Inc:

  • The MRQ is -3.9%. The company is making a loss. -1
  • The TTM is -30.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-30.5%+26.6%
TTM-30.5%YOY-50.3%+19.7%
TTM-30.5%5Y-24.9%-5.6%
5Y-24.9%10Y-30.7%+5.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.9%-6.7%+2.8%
TTM-30.5%-6.7%-23.8%
YOY-50.3%0.3%-50.6%
5Y-24.9%-1.5%-23.4%
10Y-30.7%-3.4%-27.3%
1.1.2. Return on Assets

Shows how efficient Castle Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Castle Biosciences Inc to the Diagnostics & Research industry mean.
  • -0.5% Return on Assets means that Castle Biosciences Inc generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Castle Biosciences Inc:

  • The MRQ is -0.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.5%TTM-3.3%+2.8%
TTM-3.3%YOY-3.7%+0.3%
TTM-3.3%5Y-2.0%-1.3%
5Y-2.0%10Y-0.9%-1.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.5%-1.3%+0.8%
TTM-3.3%-1.3%-2.0%
YOY-3.7%-0.9%-2.8%
5Y-2.0%-0.5%-1.5%
10Y-0.9%-0.9%0.0%
1.1.3. Return on Equity

Shows how efficient Castle Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Castle Biosciences Inc to the Diagnostics & Research industry mean.
  • -0.7% Return on Equity means Castle Biosciences Inc generated $-0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Castle Biosciences Inc:

  • The MRQ is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.7%TTM-3.7%+3.1%
TTM-3.7%YOY-4.1%+0.3%
TTM-3.7%5Y-5.1%+1.3%
5Y-5.1%10Y-4.2%-0.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.7%-0.5%-0.2%
TTM-3.7%--3.7%
YOY-4.1%0.3%-4.4%
5Y-5.1%-1.4%-3.7%
10Y-4.2%-2.3%-1.9%

1.2. Operating Efficiency of Castle Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Castle Biosciences Inc is operating .

  • Measures how much profit Castle Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Castle Biosciences Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of -8.6% means the company generated $-0.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Castle Biosciences Inc:

  • The MRQ is -8.6%. The company is operating very inefficient. -2
  • The TTM is -33.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-33.0%+24.5%
TTM-33.0%YOY-70.0%+37.0%
TTM-33.0%5Y-29.7%-3.3%
5Y-29.7%10Y-32.6%+2.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.6%-6.2%-2.4%
TTM-33.0%0.5%-33.5%
YOY-70.0%4.0%-74.0%
5Y-29.7%3.7%-33.4%
10Y-32.6%-1.3%-31.3%
1.2.2. Operating Ratio

Measures how efficient Castle Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.09 means that the operating costs are $1.09 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Castle Biosciences Inc:

  • The MRQ is 1.086. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.354. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.086TTM1.354-0.268
TTM1.354YOY1.700-0.347
TTM1.3545Y1.293+0.061
5Y1.29310Y1.322-0.029
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0861.280-0.194
TTM1.3541.304+0.050
YOY1.7001.236+0.464
5Y1.2931.242+0.051
10Y1.3221.205+0.117

1.3. Liquidity of Castle Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Castle Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 6.20 means the company has $6.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Castle Biosciences Inc:

  • The MRQ is 6.202. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.718. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.202TTM7.718-1.516
TTM7.718YOY9.264-1.546
TTM7.7185Y10.742-3.024
5Y10.74210Y9.064+1.678
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2022.111+4.091
TTM7.7182.298+5.420
YOY9.2642.599+6.665
5Y10.7423.012+7.730
10Y9.0643.081+5.983
1.3.2. Quick Ratio

Measures if Castle Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Castle Biosciences Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 8.93 means the company can pay off $8.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Castle Biosciences Inc:

  • The MRQ is 8.930. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 11.014. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.930TTM11.014-2.084
TTM11.014YOY10.951+0.063
TTM11.0145Y11.586-0.572
5Y11.58610Y9.758+1.829
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ8.9301.204+7.726
TTM11.0141.319+9.695
YOY10.9511.602+9.349
5Y11.5861.943+9.643
10Y9.7582.203+7.555

1.4. Solvency of Castle Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Castle Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Castle Biosciences Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.18 means that Castle Biosciences Inc assets are financed with 18.1% credit (debt) and the remaining percentage (100% - 18.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Castle Biosciences Inc:

  • The MRQ is 0.181. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.126. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.181TTM0.126+0.055
TTM0.126YOY0.099+0.027
TTM0.1265Y0.225-0.099
5Y0.22510Y0.248-0.023
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1810.429-0.248
TTM0.1260.407-0.281
YOY0.0990.394-0.295
5Y0.2250.450-0.225
10Y0.2480.450-0.202
1.4.2. Debt to Equity Ratio

Measures if Castle Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Castle Biosciences Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 22.1% means that company has $0.22 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Castle Biosciences Inc:

  • The MRQ is 0.221. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.146. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.221TTM0.146+0.075
TTM0.146YOY0.110+0.036
TTM0.1465Y0.876-0.730
5Y0.87610Y0.730+0.146
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2210.606-0.385
TTM0.1460.571-0.425
YOY0.1100.631-0.521
5Y0.8760.658+0.218
10Y0.7300.735-0.005

2. Market Valuation of Castle Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Castle Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Castle Biosciences Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -57.40 means the investor is paying $-57.40 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Castle Biosciences Inc:

  • The EOD is -51.894. Based on the earnings, the company is expensive. -2
  • The MRQ is -57.400. Based on the earnings, the company is expensive. -2
  • The TTM is -21.135. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-51.894MRQ-57.400+5.506
MRQ-57.400TTM-21.135-36.265
TTM-21.135YOY-30.145+9.010
TTM-21.1355Y-15.985-5.150
5Y-15.98510Y-13.321-2.664
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-51.894-0.235-51.659
MRQ-57.400-0.395-57.005
TTM-21.135-0.284-20.851
YOY-30.1450.002-30.147
5Y-15.9854.834-20.819
10Y-13.3215.200-18.521
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Castle Biosciences Inc:

  • The EOD is 6.600. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.301. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.793. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.600MRQ7.301-0.700
MRQ7.301TTM8.793-1.493
TTM8.793YOY-18.492+27.285
TTM8.7935Y-43.291+52.085
5Y-43.29110Y-36.076-7.215
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD6.600-0.277+6.877
MRQ7.301-0.441+7.742
TTM8.793-1.389+10.182
YOY-18.492-2.030-16.462
5Y-43.291-1.446-41.845
10Y-36.076-1.971-34.105
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Castle Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.51 means the investor is paying $1.51 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Castle Biosciences Inc:

  • The EOD is 1.369. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.514. Based on the equity, the company is underpriced. +1
  • The TTM is 1.332. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.369MRQ1.514-0.145
MRQ1.514TTM1.332+0.182
TTM1.332YOY1.972-0.639
TTM1.3325Y3.787-2.454
5Y3.78710Y3.156+0.631
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.3691.897-0.528
MRQ1.5142.222-0.708
TTM1.3322.168-0.836
YOY1.9723.041-1.069
5Y3.7873.477+0.310
10Y3.1564.125-0.969
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Castle Biosciences Inc.

3.1. Institutions holding Castle Biosciences Inc

Institutions are holding 89.984% of the shares of Castle Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Wasatch Advisors Inc.9.43880.3082590951-189793-6.8253
2023-12-31BlackRock Inc8.31770.001322831991470196.8823
2023-12-31Granahan Investment Management Inc..7.89241.54422166471-321202-12.9117
2023-12-31Principal Financial Group Inc5.77660.021815856731035036.9832
2023-12-31Vanguard Group Inc5.32420.00071461481220931.5349
2023-12-31Bellevue Group AG4.48950.4068123237843470.354
2023-09-30Deerfield Management Co3.44850.35239466209466200
2023-12-31Portolan Capital Management, LLC2.65451.3748728653475625187.9733
2023-12-31Millennium Management LLC2.60970.006771635012125420.3755
2023-12-31Dimensional Fund Advisors, Inc.2.41850.004266388210848119.532
2023-12-31State Street Corporation2.11260.0006579918147542.6106
2023-12-31Geode Capital Management, LLC2.06240.0013566115298795.572
2023-09-30Jacobs Levy Equity Management, Inc.1.99420.0548547403289252112.0476
2023-12-31Kornitzer Capital Management Inc1.97770.2279542874-105350-16.2521
2023-12-31Palisade Capital Management LLc1.96410.3085539135-63126-10.4815
2023-09-30Citadel Advisors Llc1.88730.0019518058461775820.452
2023-12-31Morgan Stanley - Brokerage Accounts1.74150.00094780354393891136.9585
2023-12-31Parkman Healthcare Partners LLC1.30111.085635715613256459.0244
2023-12-31Intrinsic Edge Capital Management, LLC1.18860.7037326270170000108.7861
2023-12-31Ameriprise Financial Inc1.0190.0018279727137275.1605
Total 69.61896.407819110349+2800811+14.7%

3.2. Funds holding Castle Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-11-30Bellevue Healthcare Ord4.36872.7256119920227179629.3071
2023-12-31Wasatch Ultra Growth3.50291.7322961534-133559-12.1961
2023-12-31Wasatch Small Cap Growth Investor3.00420.776582466400
2024-02-29Vanguard Total Stock Mkt Idx Inv2.90040.000979616700
2023-12-31JNL Multi-Manager Small Cap Growth A2.41890.615663980-109603-14.1682
2024-02-29iShares Russell 2000 ETF2.18280.0174599191-98-0.0164
2023-12-31Buffalo Small Cap1.83161.5216502774-105350-17.3238
2023-12-31Kornitzer Small Cap Equity1.83161.5737502774-105350-17.3238
2024-02-29Principal SmallCap R51.63530.50814489004580011.3619
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.43520.007393964-434-0.11
2023-12-31Principal U.S. Small Cap Equity1.37740.67393781003980011.7647
2023-12-31Palisade Small Cap Core Equity1.23050.5111337768-36183-9.6759
2023-12-31Strategic Advisers Small-Mid Cap1.20170.077432986100
2023-12-31Granahan SMID Select1.14994.156315649-147705-31.8774
2024-01-31M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc1.10221.921302566-57263-15.9139
2024-02-29Xtrackers S&P 500 Swap ETF 1C0.90790.049724921000
2023-12-31Fidelity Small Cap Index0.90420.021124821326811.0919
2023-12-31Wasatch Micro Cap0.85450.8043234559-74496-24.1044
2024-02-29Granahan US SMID Select I GBP Acc0.83582.5179229426-46205-16.7634
2023-12-31Victory Small Cap Stock0.71860.4239197254-4773-2.3626
Total 35.394320.63439715756-460942-4.7%

3.3. Insider Transactions

Insiders are holding 4.31% of the shares of Castle Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-04Daniel BradburySELL915221.45
2024-04-03Derek J MaetzoldSELL236821.7
2024-03-20Derek J MaetzoldSELL229520.27
2024-03-07Derek J MaetzoldSELL237220.77
2024-03-05Derek J MaetzoldSELL413121.41
2024-03-04Daniel BradburySELL2332320.68
2024-02-07Daniel BradburySELL207423.2
2024-01-04Daniel BradburySELL1822320.4
2023-12-28Derek J MaetzoldSELL395422.17
2023-12-26Derek J MaetzoldSELL518021.93
2023-12-22Derek J MaetzoldSELL522421.96
2023-12-20Derek J MaetzoldSELL520121.05
2023-12-18Derek J MaetzoldSELL572020.27
2023-12-12Daniel BradburySELL120020.01
2023-12-12Derek J MaetzoldSELL54620.01
2023-12-08Daniel BradburySELL687520.09
2023-12-08Derek J MaetzoldSELL232220.1
2023-12-06Daniel BradburySELL20020.02
2023-12-06Derek J MaetzoldSELL4820.02
2023-12-04Derek J MaetzoldSELL137920.08

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Castle Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.200-0.072+136%-0.115+157%0.731-73%0.594-66%
Book Value Per Share--14.25414.034+2%14.841-4%10.605+34%8.822+62%
Current Ratio--6.2027.718-20%9.264-33%10.742-42%9.064-32%
Debt To Asset Ratio--0.1810.126+44%0.099+83%0.225-20%0.248-27%
Debt To Equity Ratio--0.2210.146+52%0.110+102%0.876-75%0.730-70%
Dividend Per Share---0.009-100%0.015-100%0.005-100%0.004-100%
Eps---0.094-0.523+457%-0.611+551%-0.297+216%-0.263+180%
Free Cash Flow Per Share--0.739-0.125+117%-0.431+158%-0.132+118%-0.129+117%
Free Cash Flow To Equity Per Share--0.619-0.146+124%-0.417+167%0.595+4%0.501+24%
Gross Profit Margin--11.4515.277+117%5.104+124%2.676+328%2.397+378%
Intrinsic Value_10Y_max--34.804--------
Intrinsic Value_10Y_min--28.514--------
Intrinsic Value_1Y_max---0.363--------
Intrinsic Value_1Y_min---0.359--------
Intrinsic Value_3Y_max--1.844--------
Intrinsic Value_3Y_min--1.701--------
Intrinsic Value_5Y_max--7.589--------
Intrinsic Value_5Y_min--6.791--------
Market Cap535549500.000-11%592371000.000514069875.000+15%799000875.000-26%934754850.000-37%778962375.000-24%
Net Profit Margin---0.039-0.305+682%-0.503+1188%-0.249+539%-0.307+686%
Operating Margin---0.086-0.330+286%-0.700+719%-0.297+247%-0.326+281%
Operating Ratio--1.0861.354-20%1.700-36%1.293-16%1.322-18%
Pb Ratio1.369-11%1.5141.332+14%1.972-23%3.787-60%3.156-52%
Pe Ratio-51.894+10%-57.400-21.135-63%-30.145-47%-15.985-72%-13.321-77%
Price Per Share19.510-11%21.58018.728+15%29.108-26%34.053-37%28.378-24%
Price To Free Cash Flow Ratio6.600-11%7.3018.793-17%-18.492+353%-43.291+693%-36.076+594%
Price To Total Gains Ratio97.621-11%107.97915.678+589%-47.945+144%2429.571-96%2429.571-96%
Quick Ratio--8.93011.014-19%10.951-18%11.586-23%9.758-8%
Return On Assets---0.005-0.033+519%-0.037+577%-0.020+270%-0.009+75%
Return On Equity---0.007-0.037+468%-0.041+519%-0.051+669%-0.042+541%
Total Gains Per Share--0.200-0.063+131%-0.099+150%0.736-73%0.598-67%
Usd Book Value--391269000.000385242250.000+2%407394750.000-4%291108319.250+34%242170718.083+62%
Usd Book Value Change Per Share--0.200-0.072+136%-0.115+157%0.731-73%0.594-66%
Usd Book Value Per Share--14.25414.034+2%14.841-4%10.605+34%8.822+62%
Usd Dividend Per Share---0.009-100%0.015-100%0.005-100%0.004-100%
Usd Eps---0.094-0.523+457%-0.611+551%-0.297+216%-0.263+180%
Usd Free Cash Flow--20285000.000-3439000.000+117%-11821750.000+158%-3615850.000+118%-3537022.792+117%
Usd Free Cash Flow Per Share--0.739-0.125+117%-0.431+158%-0.132+118%-0.129+117%
Usd Free Cash Flow To Equity Per Share--0.619-0.146+124%-0.417+167%0.595+4%0.501+24%
Usd Market Cap535549500.000-11%592371000.000514069875.000+15%799000875.000-26%934754850.000-37%778962375.000-24%
Usd Price Per Share19.510-11%21.58018.728+15%29.108-26%34.053-37%28.378-24%
Usd Profit---2580000.000-14366500.000+457%-16425000.000+537%-7973238.350+209%-6909656.708+168%
Usd Revenue--66120000.00054947000.000+20%34259750.000+93%28271322.350+134%24508840.875+170%
Usd Total Gains Per Share--0.200-0.063+131%-0.099+150%0.736-73%0.598-67%
 EOD+3 -5MRQTTM+28 -8YOY+23 -135Y+23 -1310Y+23 -13

4.2. Fundamental Score

Let's check the fundamental score of Castle Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-51.894
Price to Book Ratio (EOD)Between0-11.369
Net Profit Margin (MRQ)Greater than0-0.039
Operating Margin (MRQ)Greater than0-0.086
Quick Ratio (MRQ)Greater than18.930
Current Ratio (MRQ)Greater than16.202
Debt to Asset Ratio (MRQ)Less than10.181
Debt to Equity Ratio (MRQ)Less than10.221
Return on Equity (MRQ)Greater than0.15-0.007
Return on Assets (MRQ)Greater than0.05-0.005
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Castle Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.402
Ma 20Greater thanMa 5020.421
Ma 50Greater thanMa 10021.207
Ma 100Greater thanMa 20021.260
OpenGreater thanClose19.070
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -381245-136-8-14473-71207136



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets477,811
Total Liabilities86,542
Total Stockholder Equity391,269
 As reported
Total Liabilities 86,542
Total Stockholder Equity+ 391,269
Total Assets = 477,811

Assets

Total Assets477,811
Total Current Assets295,635
Long-term Assets182,176
Total Current Assets
Cash And Cash Equivalents 98,841
Short-term Investments 144,258
Net Receivables 38,302
Inventory 7,942
Other Current Assets 6,292
Total Current Assets  (as reported)295,635
Total Current Assets  (calculated)295,635
+/-0
Long-term Assets
Property Plant Equipment 37,739
Goodwill 10,692
Intangible Assets 106,643
Long-term Assets Other 1,440
Long-term Assets  (as reported)182,176
Long-term Assets  (calculated)156,514
+/- 25,662

Liabilities & Shareholders' Equity

Total Current Liabilities47,667
Long-term Liabilities38,875
Total Stockholder Equity391,269
Total Current Liabilities
Short-term Debt 1,137
Accounts payable 10,268
Other Current Liabilities 36,262
Total Current Liabilities  (as reported)47,667
Total Current Liabilities  (calculated)47,667
+/-0
Long-term Liabilities
Capital Lease Obligations 15,335
Long-term Liabilities  (as reported)38,875
Long-term Liabilities  (calculated)15,335
+/- 23,540
Total Stockholder Equity
Common Stock27
Retained Earnings -218,371
Accumulated Other Comprehensive Income 136
Other Stockholders Equity 609,477
Total Stockholder Equity (as reported)391,269
Total Stockholder Equity (calculated)391,269
+/-0
Other
Capital Stock27
Cash and Short Term Investments 243,099
Common Stock Shares Outstanding 27,030
Liabilities and Stockholders Equity 477,811
Net Debt -83,531
Net Invested Capital 391,269
Net Working Capital 247,968
Property Plant and Equipment Gross 45,850
Short Long Term Debt Total 15,310



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
0
0
22,405
30,966
33,347
113,200
119,746
120,257
201,546
210,394
439,328
437,332
435,533
433,692
462,572
444,425
458,380
457,811
447,329
426,891
425,400
436,019
477,811
477,811436,019425,400426,891447,329457,811458,380444,425462,572433,692435,533437,332439,328210,394201,546120,257119,746113,20033,34730,96622,405000
   > Total Current Assets 
0
0
0
18,126
27,011
28,525
109,863
116,681
116,552
195,671
201,065
429,594
426,670
391,699
389,584
353,743
336,441
304,912
299,414
292,288
271,100
269,054
279,622
295,635
295,635279,622269,054271,100292,288299,414304,912336,441353,743389,584391,699426,670429,594201,065195,671116,552116,681109,86328,52527,01118,126000
       Cash And Cash Equivalents 
0
0
0
4,479
16,231
17,468
94,475
98,845
98,653
179,759
183,050
409,852
406,981
368,339
363,177
329,633
309,017
273,166
134,180
122,948
114,821
95,874
91,223
98,841
98,84191,22395,874114,821122,948134,180273,166309,017329,633363,177368,339406,981409,852183,050179,75998,65398,84594,47517,46816,2314,479000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131,802
135,677
117,234
129,634
138,530
144,258
144,258138,530129,634117,234135,677131,802000000000000000000
       Net Receivables 
0
0
0
12,090
9,229
9,730
12,369
14,648
14,600
12,528
12,618
12,759
14,292
17,817
18,532
17,282
19,910
22,606
22,835
23,476
27,728
31,314
37,003
38,302
38,30237,00331,31427,72823,47622,83522,60619,91017,28218,53217,81714,29212,75912,61812,52814,60014,64812,3699,7309,22912,090000
       Other Current Assets 
0
0
0
676
741
775
2,197
1,951
2,080
1,717
3,718
4,766
3,087
3,419
5,500
4,807
5,164
5,775
6,795
6,207
6,797
6,111
7,097
6,292
6,2927,0976,1116,7976,2076,7955,7755,1644,8075,5003,4193,0874,7663,7181,7172,0801,9512,197775741676000
   > Long-term Assets 
0
0
0
4,279
3,955
4,823
3,337
3,065
3,705
5,875
9,329
9,734
10,662
43,834
44,108
108,829
107,984
153,468
158,397
155,041
155,791
156,346
156,397
182,176
182,176156,397156,346155,791155,041158,397153,468107,984108,82944,10843,83410,6629,7349,3295,8753,7053,0653,3374,8233,9554,279000
       Property Plant Equipment 
0
0
0
1,529
1,720
1,743
1,798
2,060
2,733
5,024
6,646
7,102
7,780
8,092
8,866
16,884
16,604
18,207
25,658
26,496
29,655
32,050
33,886
37,739
37,73933,88632,05029,65526,49625,65818,20716,60416,8848,8668,0927,7807,1026,6465,0242,7332,0601,7981,7431,7201,529000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,494
10,486
10,692
10,700
10,700
10,692
10,692
10,69210,69210,70010,70010,69210,48610,49400000000000000000
       Intangible Assets 
0
0
0
4
2
0
0
0
0
0
0
0
0
32,798
32,104
88,922
87,275
122,177
119,871
115,656
113,426
111,179
108,907
106,643
106,643108,907111,179113,426115,656119,871122,17787,27588,92232,10432,7980000000024000
       Other Assets 
0
0
0
0
683
3,079
1,539
1,005
972
851
2,683
2,632
2,882
2,944
3,138
3,023
4,105
2,590
2,382
2,197
0
0
0
0
00002,1972,3822,5904,1053,0233,1382,9442,8822,6322,6838519721,0051,5393,0796830000
> Total Liabilities 
0
0
0
32,474
28,965
36,941
30,864
34,633
32,323
43,924
43,835
23,637
18,745
19,617
21,979
50,832
47,089
36,720
46,378
48,179
41,742
46,632
50,236
86,542
86,54250,23646,63241,74248,17946,37836,72047,08950,83221,97919,61718,74523,63743,83543,92432,32334,63330,86436,94128,96532,474000
   > Total Current Liabilities 
0
0
0
6,737
5,275
11,746
9,238
15,289
15,256
28,242
30,240
20,876
17,578
18,654
20,993
24,886
39,521
27,519
31,942
36,128
30,143
33,717
36,324
47,667
47,66736,32433,71730,14336,12831,94227,51939,52124,88620,99318,65417,57820,87630,24028,24215,25615,2899,23811,7465,2756,737000
       Short-term Debt 
0
0
0
0
3,568
5,259
3,333
5,833
8,333
10,000
10,000
62
62
10
10
1,179
1,199
1,211
1,535
1,777
1,779
1,966
1,091
1,137
1,1371,0911,9661,7791,7771,5351,2111,1991,1791010626210,00010,0008,3335,8333,3335,2593,5680000
       Short Long Term Debt 
0
0
0
0
0
5,259
3,333
5,833
8,333
10,000
10,000
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000010,00010,0008,3335,8333,3335,25900000
       Accounts payable 
0
0
0
1,451
1,609
2,085
1,251
1,865
1,934
2,495
2,101
2,098
2,172
1,368
2,766
2,546
3,314
3,281
5,768
4,731
9,961
7,135
6,929
10,268
10,2686,9297,1359,9614,7315,7683,2813,3142,5462,7661,3682,1722,0982,1012,4951,9341,8651,2512,0851,6091,451000
       Other Current Liabilities 
0
0
0
5,286
3,665
4,393
4,645
7,512
4,910
7,397
9,789
12,101
7,166
11,099
15,218
19,982
35,008
23,027
24,639
29,620
18,403
24,616
28,304
36,262
36,26228,30424,61618,40329,62024,63923,02735,00819,98215,21811,0997,16612,1019,7897,3974,9107,5124,6454,3933,6655,286000
   > Long-term Liabilities 
0
0
0
25,737
23,690
25,195
21,626
19,344
17,067
15,682
13,595
2,761
1,167
963
986
25,946
7,568
9,201
14,436
12,051
11,599
12,915
13,912
38,875
38,87513,91212,91511,59912,05114,4369,2017,56825,9469869631,1672,76113,59515,68217,06719,34421,62625,19523,69025,737000
       Long term Debt Total 
0
0
0
0
23,632
23,859
21,570
19,289
17,013
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000017,01319,28921,57023,85923,6320000
       Other Liabilities 
0
0
0
0
1,238
1,337
56
55
54
941
1,140
2,761
1,167
963
986
19,046
857
2,721
2,412
428
0
441
0
0
0044104282,4122,72185719,0469869631,1672,7611,1409415455561,3371,2380000
       Deferred Long Term Liability 
0
0
0
0
554
1,671
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,6715540000
> Total Stockholder Equity
-50,311
0
0
-10,069
2,001
-3,594
82,336
85,113
87,934
157,622
166,559
415,691
418,587
415,916
411,713
411,740
397,336
421,660
411,433
399,150
385,149
378,768
385,783
391,269
391,269385,783378,768385,149399,150411,433421,660397,336411,740411,713415,916418,587415,691166,559157,62287,93485,11382,336-3,5942,001-10,06900-50,311
   Common Stock
0
0
0
2
11
2
17
17
17
19
20
25
25
25
25
25
25
26
26
27
27
27
27
27
2727272727262625252525252520191717172112000
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-909
-987
-1,012
-1,103
-1,203
-1,293
-1,396
-1,498
0
0
0
0
0
0
0
-189
-381
-136
-144
-71
136
136-71-144-136-381-1890000000-1,498-1,396-1,293-1,203-1,103-1,012-987-909000
   Capital Surplus 
0
0
0
0
9,412
9,911
136,585
137,308
139,559
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000139,559137,308136,5859,9119,4120000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
1,831
61,823
10,923
-113,062,559
138,511
140,852
212,017
225,644
478,162
485,338
491,458
499,046
505,482
515,701
541,672
551,883
560,409
575,367
587,771
601,618
609,477
609,477601,618587,771575,367560,409551,883541,672515,701505,482499,046491,458485,338478,162225,644212,017140,852138,511-113,062,55910,92361,8231,831000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue219,788
Cost of Revenue-55,554
Gross Profit164,234164,234
 
Operating Income (+$)
Gross Profit164,234
Operating Expense-232,211
Operating Income-67,977-67,977
 
Operating Expense (+$)
Research Development53,288
Selling General Administrative66,495
Selling And Marketing Expenses113,657
Operating Expense232,211233,440
 
Net Interest Income (+$)
Interest Income9,779
Interest Expense-11
Other Finance Cost-2
Net Interest Income9,766
 
Pretax Income (+$)
Operating Income-67,977
Net Interest Income9,766
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-57,365-78,589
EBIT - interestExpense = -67,988
-57,365
-57,455
Interest Expense11
Earnings Before Interest and Taxes (EBIT)-67,977-57,354
Earnings Before Interest and Taxes (EBITDA)-55,647
 
After tax Income (+$)
Income Before Tax-57,365
Tax Provision-119
Net Income From Continuing Ops-75,504-57,484
Net Income-57,466
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses287,765
Total Other Income/Expenses Net10,612-9,766
 

Technical Analysis of Castle Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Castle Biosciences Inc. The general trend of Castle Biosciences Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Castle Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Castle Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 22.26 < 22.67 < 25.36.

The bearish price targets are: 18.53 > 18.50 > 17.42.

Tweet this
Castle Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Castle Biosciences Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Castle Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Castle Biosciences Inc. The current macd is -0.45111963.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Castle Biosciences Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Castle Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Castle Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Castle Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartCastle Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Castle Biosciences Inc. The current adx is 18.63.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Castle Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Castle Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Castle Biosciences Inc. The current sar is 21.22.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Castle Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Castle Biosciences Inc. The current rsi is 43.40. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Castle Biosciences Inc Daily Relative Strength Index (RSI) ChartCastle Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Castle Biosciences Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Castle Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Castle Biosciences Inc Daily Stochastic Oscillator ChartCastle Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Castle Biosciences Inc. The current cci is -77.47760629.

Castle Biosciences Inc Daily Commodity Channel Index (CCI) ChartCastle Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Castle Biosciences Inc. The current cmo is -15.20089398.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Castle Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartCastle Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Castle Biosciences Inc. The current willr is -67.20779221.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Castle Biosciences Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Castle Biosciences Inc Daily Williams %R ChartCastle Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Castle Biosciences Inc.

Castle Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Castle Biosciences Inc. The current atr is 0.90083522.

Castle Biosciences Inc Daily Average True Range (ATR) ChartCastle Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Castle Biosciences Inc. The current obv is 11,426,251.

Castle Biosciences Inc Daily On-Balance Volume (OBV) ChartCastle Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Castle Biosciences Inc. The current mfi is 49.11.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Castle Biosciences Inc Daily Money Flow Index (MFI) ChartCastle Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Castle Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Castle Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Castle Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.402
Ma 20Greater thanMa 5020.421
Ma 50Greater thanMa 10021.207
Ma 100Greater thanMa 20021.260
OpenGreater thanClose19.070
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Castle Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Castle Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Castle Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Castle Biosciences Inc

I send you an email if I find something interesting about Castle Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Castle Biosciences Inc.

Receive notifications about Castle Biosciences Inc in your mailbox!